Innovative Therapy
Our objective at REMFS LLC is to develop a novel multitarget, effective, and safe non-invasive approach utilizing Repeated Electromagnetic Field Stimulation (REMFS) therapy using electromagnetic radiation at 64 MHz to decrease the toxic Aβ levels in the brain of Alzheimer’s disease patients. Late Onset Alzheimer’s Disease (LOAD) is the most common cause of dementia, characterized by the deposition of plaques primarily of neurotoxic amyloid-β (Aβ) peptide and tau protein.
Innovative Alzheimer’s Therapy
At REMFS LLC, we pioneer a non invasive therapy. The medical project proposed here has three phases: The initial phase of determining the research parameters for reducing Aβ levels in human brain cultures and animal studies was completed at the IUSM. The translational engineering of A Novel Design Of A Portable Birdcage Via Meander Line Antenna (MLA). The REMS device and the numerical head and Antenna devices was successfully completed by Purdue University and IUSM. Future phases will require manufacture and experimental validation of the REMS device with FDA approval for human application.
Innovative Electromagnetic Therapy
Developing noninvasive solutions to reduce toxic aβ levels in Alzheimer’s patients.
Innovative Alzheimer’s Therapy
Join us in pioneering noninvasive electromagnetic treatments to reduce toxic aβ levels in Alzheimer’s patients.
Contact Us
email@email.com